Stem Cell Related Patent Number US6143292

Allogeneic cell therapy for cancer following allogeneic stem cell transplantation

Slavin, Shimon; Jerusalem, Israel

Described herein are allogeneic lymphocytes and methods of their use. The invention relates to a process of administering allogeneic lymphocytes in the treatment of a human cancer patient having a solid malignant tumor. Specific therapeutic applications are provided, such as for inducing a graft-versus-tumor response in the treatment of solid tumors and leukemia with allogeneic lymphocytes after allogeneic stem cell transplantation.

Application Number: US1997000930071

Date Filed: 11/21/97

Dated Published: 11/07/00

Assignee: Baxter International Inc., Deerfield, IL, USA